|
US5200313A
(en)
|
1983-08-05 |
1993-04-06 |
Miles Inc. |
Nucleic acid hybridization assay employing detectable anti-hybrid antibodies
|
|
US4777245A
(en)
|
1984-01-06 |
1988-10-11 |
Genelabs Incorporated |
Non-human primate monoclonal antibodies and methods
|
|
US4921698A
(en)
|
1984-05-25 |
1990-05-01 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Polypeptide having gamma-interferon activity lacking amino acids coded by exon 4
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5073492A
(en)
|
1987-01-09 |
1991-12-17 |
The Johns Hopkins University |
Synergistic composition for endothelial cell growth
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
NZ235148A
(en)
*
|
1989-09-05 |
1991-12-23 |
Immunex Corp |
Tumour necrosis factor receptor protein and dna sequences
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5744500A
(en)
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
AT396939B
(de)
|
1990-05-29 |
1993-12-27 |
Alois Dipl Ing Dr Jungbauer |
Komplexes virales antigen von hiv-1 bindendes rekombinantes protein
|
|
ES2236682T5
(es)
|
1991-01-21 |
2011-03-31 |
Elan Pharmaceuticals, Inc. |
Ensayo y modelo para la enfermedad de alzheimer.
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
US6270766B1
(en)
*
|
1992-10-08 |
2001-08-07 |
The Kennedy Institute Of Rheumatology |
Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
|
|
GB9225453D0
(en)
|
1992-12-04 |
1993-01-27 |
Medical Res Council |
Binding proteins
|
|
EP0679716A4
(en)
|
1993-11-12 |
1999-06-09 |
Kenichi Matsubara |
GENE SIGNATURE.
|
|
JPH07132033A
(ja)
|
1993-11-12 |
1995-05-23 |
Hoechst Japan Ltd |
アルツハイマー病モデルトランスジェニック動物
|
|
US20030198640A1
(en)
|
1994-11-07 |
2003-10-23 |
Human Genome Sciences, Inc. |
Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
|
|
ES2281898T3
(es)
|
1994-12-13 |
2007-10-01 |
Human Genome Sciences, Inc. |
Inhibidor tisular humano de metaloproteinasa-4.
|
|
US6544761B2
(en)
|
1994-12-13 |
2003-04-08 |
Human Genome Sciences, Inc. |
Human tissue inhibitor of metalloproteinase-4
|
|
ES2176484T3
(es)
|
1995-08-18 |
2002-12-01 |
Morphosys Ag |
Bancos de proteinas/(poli)peptidos.
|
|
MX336813B
(es)
*
|
1996-02-09 |
2016-02-02 |
Abbvie Biotechnology Ltd |
Anticuerpos humanos que ligan el tnfa humano.
|
|
US7129061B1
(en)
*
|
1996-08-07 |
2006-10-31 |
Biogen Idec Ma Inc. |
Tumor necrosis factor related ligand
|
|
CZ297387B6
(cs)
|
1996-08-07 |
2006-11-15 |
Biogen Idec Ma Inc. |
Sekvence DNA kódující ligand príbuzný TNF, polypeptid a zpusob jeho prípravy, protilátka reaktivní s polypeptidem a farmaceutická kompozice
|
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
|
US5858991A
(en)
|
1997-01-29 |
1999-01-12 |
Vanderbilt University |
Facilitation of wound healing with CM101/GBS toxin
|
|
CA2280231A1
(en)
*
|
1997-02-12 |
1998-08-13 |
Abbott Laboratories |
Member of the tnf family useful for treatment and diagnosis of disease
|
|
US7368531B2
(en)
|
1997-03-07 |
2008-05-06 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
|
EP0983303B1
(en)
|
1997-05-21 |
2006-03-08 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
US7001992B2
(en)
|
1997-05-30 |
2006-02-21 |
Human Genome Sciences, Inc. |
Antibodies to secreted protein HEMCM42
|
|
ATE487737T1
(de)
|
1997-05-30 |
2010-11-15 |
Human Genome Sciences Inc |
32 humane sekretierte proteine
|
|
AU7549498A
(en)
|
1997-06-03 |
1998-12-21 |
Protegene Inc. |
Human proteins having transmembrane domains and dnas encoding these prot eins
|
|
WO1999011791A2
(en)
|
1997-09-05 |
1999-03-11 |
University Of Washington |
Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
|
|
JP4303883B2
(ja)
|
1997-09-18 |
2009-07-29 |
ジェネンテック・インコーポレーテッド |
ＤｃＲ３ポリペプチドというＴＮＦＲ相同体
|
|
EP1021542B1
(en)
|
1997-10-10 |
2009-03-04 |
Genentech, Inc. |
Apo-3 ligand
|
|
US20020072089A1
(en)
|
1999-11-23 |
2002-06-13 |
Holtzman Douglas A. |
Novel ITALY, Lor-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor
|
|
US6046381A
(en)
|
1998-04-30 |
2000-04-04 |
The Regents Of The University Of California |
Apolipoprotein E transgenic mice and assay methods
|
|
WO1999059614A1
(en)
|
1998-05-20 |
1999-11-25 |
Yale University |
Modulation of angiogenesis and wound healing
|
|
EP1080194A2
(en)
|
1998-05-29 |
2001-03-07 |
Incyte Pharmaceuticals, Inc. |
Human transmembrane proteins
|
|
CA2345382A1
(en)
|
1998-10-16 |
2000-04-27 |
Immunex Corporation |
Inhibitors of platelet activation and recruitment
|
|
AU776910B2
(en)
|
1998-12-08 |
2004-09-23 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Modifying protein immunogenicity
|
|
ES2327785T3
(es)
|
1998-12-22 |
2009-11-03 |
Genentech, Inc. |
Procedimientos y compuestos para inhibir el crecimiento de celulas neoplasticas.
|
|
MXPA01007163A
(es)
|
1999-01-15 |
2002-03-27 |
Biogen Inc |
Antagonistas de tweak y de receptores de tweak y su uso para tratar trastornos inmunologicos.
|
|
US20020004041A1
(en)
|
1999-02-19 |
2002-01-10 |
Albert Matthew L. |
Methods for abrogating a cellular immune response
|
|
PT1626058E
(pt)
|
1999-03-08 |
2008-02-15 |
Genentech Inc |
Composições e métodos para o diagnóstico de tumores
|
|
US6521424B2
(en)
|
1999-06-07 |
2003-02-18 |
Immunex Corporation |
Recombinant expression of Tek antagonists
|
|
KR100510795B1
(en)
|
1999-08-31 |
2005-08-30 |
|
Compositions and Methods for the Treatment of Tumor
|
|
US6727225B2
(en)
*
|
1999-12-20 |
2004-04-27 |
Immunex Corporation |
TWEAK receptor
|
|
US7495086B2
(en)
*
|
1999-12-20 |
2009-02-24 |
Immunex Corporation |
TWEAK receptor
|
|
EP2298333A3
(en)
|
1999-12-20 |
2012-05-02 |
Immunex Corporation |
Tweak receptor
|
|
IL150571A0
(en)
|
2000-01-03 |
2003-02-12 |
Tr Associates L L C |
Novel chimeric proteins and methods for using the same
|
|
US7927602B2
(en)
|
2002-07-23 |
2011-04-19 |
University Of Louisville Research Foundation, Inc. |
Fas ligand-avidin/streptavidin fusion proteins
|
|
EP1252143A1
(en)
|
2000-01-27 |
2002-10-30 |
American Cyanamid Company |
Method for preparing alpha-sulfonyl hydroxamic acid derivatives
|
|
NZ521437A
(en)
|
2000-02-25 |
2004-04-30 |
Immunex Corp |
Integrin antagonists suitable as inhibitors of angiogenesis
|
|
US6608048B2
(en)
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
|
AU5951901A
(en)
*
|
2000-05-08 |
2001-11-20 |
Biogen Inc |
Method for promoting neovascularization
|
|
US7498304B2
(en)
|
2000-06-16 |
2009-03-03 |
Curis, Inc. |
Angiogenesis-modulating compositions and uses
|
|
US20040047854A1
(en)
|
2001-07-27 |
2004-03-11 |
Black Roy A. |
Human disintegrin protein
|
|
US7208151B2
(en)
|
2001-09-12 |
2007-04-24 |
Biogen Idec Ma Inc. |
Tweak receptor agonists as anti-angiogenic agents
|
|
AU8901901A
(en)
|
2000-09-14 |
2002-03-26 |
Biogen Inc |
Tweak receptor agonists as anti-angiogenic agents background
|
|
AU1305302A
(en)
|
2000-10-05 |
2002-04-15 |
Immunex Corp |
Nectin polypeptides, polynucleotides, methods of making and use thereof
|
|
JP4344519B2
(ja)
|
2000-12-28 |
2009-10-14 |
旭化成ファーマ株式会社 |
ＮＦ−κＢ活性化遺伝子
|
|
EP1379264A4
(en)
|
2001-03-21 |
2009-07-08 |
Human Genome Sciences Inc |
HUMAN SECRETED PROTEINS
|
|
US20040203083A1
(en)
|
2001-04-13 |
2004-10-14 |
Biosite, Inc. |
Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
|
|
EP1390497A2
(en)
|
2001-05-25 |
2004-02-25 |
Genset |
Human cdnas and proteins and uses thereof
|
|
US20040076955A1
(en)
|
2001-07-03 |
2004-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
|
|
WO2003040307A2
(en)
|
2001-07-27 |
2003-05-15 |
Human Genome Sciences, Inc. |
Heteromultimeric tnf ligand family members
|
|
US20040091473A1
(en)
|
2001-07-27 |
2004-05-13 |
Dubose Robert F. |
Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
|
|
US20030148314A1
(en)
|
2001-08-01 |
2003-08-07 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer
|
|
US20040033495A1
(en)
|
2001-08-03 |
2004-02-19 |
Eos Biotechnology, Inc. |
Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
|
|
US7087225B2
(en)
|
2001-08-16 |
2006-08-08 |
Human Genome Sciences, Inc. |
Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
|
|
MX352180B
(es)
*
|
2002-04-09 |
2017-11-13 |
Biogen Ma Inc |
El uso de antagonistas de tweak para el tratamiento de condiciones relacionadas con tweak.
|
|
US7754884B2
(en)
|
2005-01-03 |
2010-07-13 |
Vanderbilt University |
Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
|
|
CA2512729C
(en)
|
2003-01-09 |
2014-09-16 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
|
WO2004063355A2
(en)
|
2003-01-10 |
2004-07-29 |
Protein Design Labs, Inc. |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
|
|
WO2004065416A2
(en)
|
2003-01-16 |
2004-08-05 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
WO2004074433A2
(en)
|
2003-01-30 |
2004-09-02 |
Yale University |
Rag polypeptides, nucleic acids, and their use
|
|
WO2004074506A2
(en)
|
2003-02-13 |
2004-09-02 |
Mergen Ltd |
Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers
|
|
WO2004072266A2
(en)
|
2003-02-13 |
2004-08-26 |
Kalobios Inc. |
Antibody affinity engineering by serial epitope-guided complementarity replacement
|
|
WO2004079014A2
(en)
|
2003-03-04 |
2004-09-16 |
Arcturus Bioscience, Inc. |
Signatures of er status in breast cancer
|
|
DE602004006871T2
(de)
|
2003-07-24 |
2008-02-07 |
Amgen Inc., Thousand Oaks |
Zusammensetzungen und verfahren, die multimere und oligomere lösliche fragmente des tweak-rezeptors betreffen
|
|
EP1566636A1
(en)
|
2004-02-23 |
2005-08-24 |
AXARON Bioscience AG |
Use of Tweak modulators and inhibitors for the treatment of neurological conditions
|
|
EP1811838A4
(en)
|
2004-11-08 |
2009-07-22 |
Univ Maryland |
TWEAK AS A THERAPEUTIC TARGET FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM IN CONNECTION WITH CEREBRAL OEDEM AND CELL DEATH
|
|
US7939490B2
(en)
*
|
2004-12-13 |
2011-05-10 |
University Of Maryland, Baltimore |
TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death
|
|
US20090068102A1
(en)
*
|
2005-02-17 |
2009-03-12 |
Biogen Idec Ma Inc. |
Treating stroke
|
|
WO2006089095A2
(en)
|
2005-02-17 |
2006-08-24 |
Biogen Idec Ma Inc. |
Treating neurological disorders
|
|
EP1853312B1
(en)
|
2005-03-07 |
2014-12-10 |
Genentech, Inc. |
Methods and compositions for modulating tweak and fn14 activity
|
|
CA2607697C
(en)
|
2005-05-10 |
2015-01-06 |
Biogen Idec Ma Inc. |
Treating and evaluating inflammatory disorders
|
|
WO2006130429A2
(en)
|
2005-05-27 |
2006-12-07 |
Biogen Idec Ma Inc. |
Treatment of cancer
|
|
MEP35408A
(en)
|
2005-05-27 |
2011-02-10 |
Biogen Idec Inc |
Tweak binding antibodies
|
|
WO2006138219A2
(en)
|
2005-06-13 |
2006-12-28 |
Biogen Idec Ma Inc. |
Methods of diagnosis / prognosis of inflammatory conditions
|
|
US20100284933A1
(en)
|
2006-10-16 |
2010-11-11 |
Biogen Idec Ma Inc. |
Biomarkers of Multiple Sclerosis
|
|
MX2010012324A
(es)
|
2008-05-15 |
2011-01-14 |
Biogen Idec Inc |
Anticuerpos anti-fn14 y usos de los mismos.
|
|
WO2010085648A2
(en)
|
2009-01-23 |
2010-07-29 |
Linda Burkly C |
Methods for reducing radiation-induced tissue damage
|
|
MX2011007936A
(es)
|
2009-01-30 |
2011-08-17 |
Biogen Idec Inc |
Metodos para regeneracion de tejido pancreatico.
|
|
AU2011311673B2
(en)
|
2010-10-05 |
2015-09-17 |
F. Hoffmann-La Roche Ag |
Antibodies against human TWEAK and uses thereof
|